MARSHALL WACE ASIA Ltd - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 141 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE ASIA Ltd ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q2 2021$1,305,000
+374.5%
33,243
+241.8%
0.03%
+366.7%
Q1 2021$275,000
-56.9%
9,727
-58.0%
0.01%
-57.1%
Q2 2020$638,000
+6280.0%
23,139
+4169.2%
0.01%
Q1 2020$10,000
-85.9%
542
-86.4%
0.00%
-100.0%
Q3 2019$71,000
-77.8%
3,976
-62.6%
0.00%
-81.8%
Q2 2018$320,00010,6200.01%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,684,118$84,523,00016.48%
Cederberg Capital Ltd 3,400,000$108,868,0002.00%
Capital International Sarl 570,500$18,267,0001.91%
AIA Group Ltd 437,118$14,971,0001.72%
Capital International, Inc./CA/ 4,711,405$150,859,0001.40%
M&G INVESTMENT MANAGEMENT LTD 3,096,345$99,083,0000.62%
Bellevue Group AG 947,674$30,345,0000.35%
Sands Capital Management 7,051,916$225,802,0000.22%
E Fund Management (Hong Kong) Co., Ltd. 18,836$603,0000.21%
Hudson Bay Capital Management LP 1,031,212$33,020,0000.18%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders